John K Bakewell
CIK 1183553 · SVP, Research & Development · last filed 2026-08-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TMCI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
664 CRUISER LANE
BELGRADE, MT 59714
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XTNT | Director | 1,129,633 | $0.28 | $310.8K | $0 | 10 | 2026-08-18 |
| TMCI | Director | 454,056 | $4.42 | $2.01M | $594.6K | 8 | 2026-05-19 |
| STIM | Director | 114,352 | $2.24 | $256.1K | -$38.9K | 5 | 2023-05-26 |
| Corindus Vascular Robotics, Inc. (CVRS) Delisted | Director | 32,072 | — | — | $0 | 2 | 2018-03-06 |
| ENTL | Director | 0 | $6.64 | $0 | $0 | 4 | 2018-03-01 |
| EXACT SCIENCES CORP (EXAS) Delisted | Chief Financial Officer | — | $104.91 | — | $0 | 1 | 2016-01-05 |
| LNTH | CFO and Treasurer | 0 | $99.92 | $0 | $0 | 3 | 2016-01-04 |
| ev3 Inc. (EVVV) Delisted | Director | 4,148 | — | — | $0 | 5 | 2010-07-13 |
Recent Filings · Page 3 of 5
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-28 | STIM | Grant (A) | +30,000 | $0 | EDGAR |
| 2020-02-07 | XTNT | Grant (A) | +116,197 | $0 | EDGAR |
| 2019-09-25 | XTNT | Grant (A) | +5,555 | $0 | EDGAR |
| 2018-04-10 | XTNT | Grant (A) | +26,042 | $0 | EDGAR |
| 2018-03-06 | Corindus Vascular Robotics, Inc. (CVRS) Delisted | Grant (A) | +32,072 | $0 | EDGAR |
| 2018-03-01 | ENTL | Disp (D) | −2,500 | -$60.0K | EDGAR |
| 2017-12-19 | Corindus Vascular Robotics, Inc. (CVRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-14 | ENTL | Grant (A) | +2,500 | $0 | EDGAR |
| 2016-06-15 | ENTL | Grant (A) | — | $0 | EDGAR |
| 2016-01-05 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.